These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11745838)

  • 1. Sources of variability in birth defects prevalence rates.
    Hobbs CA; Hopkins SE; Simmons CJ
    Teratology; 2001; 64 Suppl 1():S8-S13. PubMed ID: 11745838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Random error and undercounting in birth defects surveillance data: implications for inference.
    Correa-Villaseñor A; Satten GA; Rolka H; Langlois P; Devine O
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):610-6. PubMed ID: 14703782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National rates of birth defects among hospitalized newborns.
    Bird TM; Hobbs CA; Cleves MA; Tilford JM; Robbins JM
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):762-9. PubMed ID: 17063529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth defects interstate data exchange: a battle worth fighting?
    Cassell C; Mai C; Rickard R
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):806-10. PubMed ID: 17990342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CUSUM and Shewhart charts to monitor regional trends of birth defect reports in New York State.
    Babcock GD; Talbot TO; Rogerson PA; Forand SP
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):669-78. PubMed ID: 16240377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study.
    Canfield MA; Collins JS; Botto LD; Williams LJ; Mai CT; Kirby RS; Pearson K; Devine O; Mulinare J;
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):679-89. PubMed ID: 16240378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using active birth defects surveillance programs to supplement data on fetal death reports: improving surveillance data on stillbirths.
    Duke W; Williams L; Correa A
    Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):799-804. PubMed ID: 18985684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of selected characteristics of pregnancy drug registries.
    Honein MA; Paulozzi LJ; Cragan JD; Correa A
    Teratology; 1999 Dec; 60(6):356-64. PubMed ID: 10590397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of using the national hospital discharge survey to estimate the prevalence of selected birth defects.
    Boulet SL; Correa-Villaseñor A; Hsia J; Atrash H
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):757-61. PubMed ID: 17094134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.
    Wang Y; Sharpe-Stimac M; Cross PK; Druschel CM; Hwang SA
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):663-8. PubMed ID: 16240383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registry to referral: using birth defects registries to refer infants and toddlers for early intervention services.
    Farel AM; Meyer RE; Hicken M; Edmonds LD
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):647-50. PubMed ID: 14703788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating prevalence of fetal alcohol syndrome (FAS): effectiveness of a passive birth defects registry system.
    Fox DJ; Druschel CM
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):604-8. PubMed ID: 14703781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid.
    Robbins JM; Tilford JM; Bird TM; Cleves MA; Reading JA; Hobbs CA
    Pediatrics; 2006 Sep; 118(3):906-15. PubMed ID: 16950980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological issues in setting up a surveillance system for birth defects in India.
    Suresh S; Thangavel G; Sujatha J; Indrani S
    Natl Med J India; 2005; 18(5):259-62. PubMed ID: 16433142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of seasonal variation of birth defects in Atlanta.
    Siffel C; Alverson CJ; Correa A
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):655-62. PubMed ID: 16240376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of including elective pregnancy terminations before 20 weeks gestation on birth defect rates.
    Ethen MK; Canfield MA
    Teratology; 2002; 66 Suppl 1():S32-5. PubMed ID: 12239742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collection, use, and protection of population-based birth defects surveillance data in the united states.
    Mai CT; Law DJ; Mason CA; McDowell BD; Meyer RE; Musa D;
    Birth Defects Res A Clin Mol Teratol; 2007 Dec; 79(12):811-4. PubMed ID: 18064713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 54(51):1301-5. PubMed ID: 16397457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascertainment of pregnancies terminated because of birth defects: effect on completeness of adding a new source of data.
    Bower C; Ryan A; Rudy E
    Teratology; 2001 Jan; 63(1):23-5. PubMed ID: 11169551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
    Colvin J; Bower C; Dickinson JE; Sokol J
    Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.